BioAge Labs, Inc.
NASDAQ:BIOA · NASDAQ Global Select
+$0.47 today
Vol 0.62M · Avg 0.46M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+378.57%
Period High
$22.92
Period Low
$4.12
Latest
$20.77
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$484.08M
Cabaletta Bio, Inc.
NASDAQ:CABA
$471.16M
Canopy Growth Corporation
NASDAQ:CGC
$402.40M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$344.92M
Alpha Teknova, Inc.
NASDAQ:TKNO
$279.33M
Editas Medicine, Inc.
NASDAQ:EDIT
$255.03M
Lifecore Biomedical, Inc.
NASDAQ:LFCR
$207.31M
Owens & Minor, Inc.
OMI
$207.07M
Aurora Cannabis Inc.
NASDAQ:ACB
$165.87M
Humacyte, Inc.
NASDAQ:HUMA
$153.74M
What is the latest BIOA filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does BIOA have?
Intrinsic Alpha currently shows 20 recent filings for BIOA.
Explore More
Continue the stock analysis
Jump to another research area for this company.